搜尋結果
Why One Banker Is on a Personal Mission To Prevent Elder Fraud
ACCESSWIRE· 2 年前NORTHAMPTON, MA / ACCESSWIRE / October 19, 2022 / Chad Schrieber wants to help others avoid ...
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, ...
ACCESSWIRE· 1 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
Ministry of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug ...
ACCESSWIRE· 2 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
Merck and Moderna Announce Exercise of Option by Merck for Joint Development and ...
ACCESSWIRE· 2 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
Be Proactive About PFAS with This PFAS Action Plan Guide
ACCESSWIRE· 2 年前Chemicals that belong to the family of per-and poly-fluoroalkyl substances (PFAS) are back in ...
Lung Cancer Is Personal: Interview With Lee James
ACCESSWIRE· 2 年前NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Bristol Myers Squibb Company non-small cell ...
Griffith Foods: Carbs in a New Light
ACCESSWIRE· 2 年前When it comes to carbohydrates, it's the quality-not quantity-that matters most. With ...
藥明巨諾宣佈與 2seventy bio達成獨家戰略合作,開發自身免疫疾病CAR-T治療產品
PR Newswire Asia· 4 個月前上海2024年1月2日 /美通社/ -- 藥明巨諾(港交所代碼:2126),一家獨立的、專注於研發、生產及商業化 ...
【錯誤】網傳「主流媒體美國ABC電視台 終於承認----第 4 劑疫苗接種可能會關閉您的免疫系統 」?
台灣事實查核中心 via Yahoo奇摩新聞· 2 年前事實查核報告#1878 網傳「主流媒體美國ABC電視台 終於承認----第 4 劑疫苗接種可能會關閉您的免疫系統 ...
藥明巨諾與2seventy bio宣佈達成戰略合作,加速T細胞免疫治療的研發
PR Newswire Asia· 2 年前雙方的首要合作是在中國加速開發用於治療實體腫瘤的2seventy的MAGE-A4項目 中國上海和美國馬薩諸塞州 ...